• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可植入式角膜胶原晶状体V4和V4c矫正高度近视的疗效——病例系列

Outcomes of implantable collamer lens V4 and V4c for correction of high myopia - a case series.

作者信息

Karandikar Smita, Bhandari Vipul, Reddy Jagdeesh

出版信息

Nepal J Ophthalmol. 2015 Jul;7(14):164-72. doi: 10.3126/nepjoph.v7i2.14967.

DOI:10.3126/nepjoph.v7i2.14967
PMID:27363962
Abstract

OBJECTIVE

To evaluate the visual outcomes and intraocular pressure changes after Visian Implantable Collamer Lens (ICL) implantation V4b and V4c (with centraflow technology) for correction of myopia.

MATERIALS AND METHODS

A prospective, consecutive, comparative interventional case series of V4b and V4c ICL implantation done for correction of high myopia (>-6 diopter D) in patients unsuitable for laser vision correction. The outcome measures that were evaluated included preoperative and postoperative uncorrected distant visual acuity (UDVA), best spectacle corrected distant visual acuity (CDVA), endothelial cell count (ECC), presence of lens opacification, intraocular pressure (IOP) and ICL vaulting. A follow-up of upto 1 year was done. A questionnaire was given at the end of follow-up period.

RESULTS

A total of 30 eyes (24.56±4.8 years) underwent V4b ICL implantation (10 non-toric, 20 toric ICL-TICL) with intraoperative peripheral iridectomy (PI) and 34 eyes (26.13±3.8 years) had implantation of V4c ICL with centraflow (12 non-toric, 22 TICL). The mean preoperative manifest spherical equivalent (MSE) was 8.98±2.8 D and 9.24±2.4 D in the V4b and V4c groups respectively which reduced to postoperative values of -0.28±1.3 D and -0.19±1.18 D respectively. The mean preoperative astigmatism was -1.8±1.2 diopter cylinder (Dcyl) and -1.9±1.6 Dcyl which respectively reduced to -0.8±0.8 Dcyl and -0.9±0.3 Dcyl. At the end of 1 year follow up, mean ECC loss was 7.6% and 7.1%, mean vault was 583.12±231.12 μ and 602±241.24μ respectively in the V4b and V4c groups. Anterior subcapsular opacities were present in 6.66% and 2.94% of eyes with V4b and V4c groups respectively. Two eyes from both V4b (10%) and V4c (8.33%) had rotation of more than 30 degrees and required re-rotation surgery done successfully. Two eyes (6.66%) with V4b ICL implantation had high postoperative IOP (>35 mm Hg) and required Nd:Yag laser iridotomy later done with successful control of IOP. The safety indices were 1.12 and 1.15 and efficacy indices were 1.5 and 1.6 in the V4b and V4c groups respectively at the end of 1 year. The most common visual complaint was glare and haloes in 24% and 27% in the two groups respectively. However, they were not annoying enough to cause visual disability.

CONCLUSIONS

Both V4b and V4c Visian ICL implantations are comparable in terms of visual outcome and safety profile for correction of high myopia. However, V4c ICL offers these advantages without the requirement of an additional PI.

摘要

目的

评估Visian可植入式角膜接触镜(ICL)V4b和V4c(采用中央流体技术)植入术后的视力结果和眼压变化,用于矫正近视。

材料与方法

这是一项前瞻性、连续性、对比性干预病例系列研究,对不适合激光视力矫正的高度近视(>-6屈光度D)患者进行V4b和V4c ICL植入。评估的结果指标包括术前和术后未矫正远视力(UDVA)、最佳矫正远视力(CDVA)、内皮细胞计数(ECC)、晶状体混浊情况、眼压(IOP)和ICL拱高。随访时间长达1年。随访结束时发放问卷。

结果

共有30只眼(24.56±4.8岁)接受了V4b ICL植入(10只非散光型,20只散光型ICL-TICL)并在术中进行周边虹膜切除术(PI),34只眼(26.13±3.8岁)植入了带中央流体的V4c ICL(12只非散光型,22只TICL)。V4b组和V4c组术前平均等效球镜度(MSE)分别为8.98±2.8 D和9.24±2.4 D,术后分别降至-0.28±1.3 D和-0.19±1.18 D。术前平均散光分别为-1.8±1.2屈光度柱镜(Dcyl)和-1.9±1.6 Dcyl,术后分别降至-0.8±0.8 Dcyl和-0.9±0.3 Dcyl。在1年随访结束时,V4b组和V4c组平均ECC损失分别为7.6%和7.1%,平均拱高分别为583.12±231.12μm和602±241.24μm。V4b组和V4c组分别有6.66%和2.94%的眼出现前囊下混浊。V4b组和V4c组各有2只眼(分别为10%和8.33%)发生旋转超过30度,需行再次旋转手术且手术成功。2只接受V4b ICL植入的眼(6.66%)术后眼压高(>35 mmHg),随后行Nd:YAG激光虹膜切开术,眼压得到成功控制。1年随访结束时,V4b组和V4c组的安全指数分别为1.12和1.15,有效指数分别为1.5和1.6。两组中最常见的视觉主诉分别为眩光和光晕,发生率分别为24%和27%。然而,它们并不足以令人烦恼到导致视力残疾。

结论

V4b和V4c Visian ICL植入在矫正高度近视的视力结果和安全性方面具有可比性。然而,V4c ICL具有这些优势且无需额外的PI。

相似文献

1
Outcomes of implantable collamer lens V4 and V4c for correction of high myopia - a case series.可植入式角膜胶原晶状体V4和V4c矫正高度近视的疗效——病例系列
Nepal J Ophthalmol. 2015 Jul;7(14):164-72. doi: 10.3126/nepjoph.v7i2.14967.
2
Implantable collamer lens V4b and V4c for correction of high myopia.用于矫正高度近视的可植入式胶原晶状体V4b和V4c
J Curr Ophthalmol. 2016 Feb 9;27(3-4):76-81. doi: 10.1016/j.joco.2016.01.001. eCollection 2015 Sep-Dec.
3
Intraocular pressure after implantation of the Visian Implantable Collamer Lens With CentraFLOW without iridotomy.植入 Visian 可植入 Collamer 透镜后不进行虹膜切开术的眼内压。
Am J Ophthalmol. 2013 Oct;156(4):800-5. doi: 10.1016/j.ajo.2013.05.018. Epub 2013 Jul 20.
4
Long-term Comparison of Vault and Complications of Implantable Collamer Lens with and without a Central Hole for High Myopia Correction: 5 Years.长期比较植入 Collamer 透镜穹顶和并发症,有中央孔和无中央孔用于高度近视矫正:5 年。
Curr Eye Res. 2022 Apr;47(4):540-546. doi: 10.1080/02713683.2021.2012202. Epub 2021 Dec 12.
5
Comparison of Implantable Collamer Lens Visian ICL V4 and ICL V4c for high myopia: A cohort study.可植入式Collamer晶状体Visian ICL V4与ICL V4c治疗高度近视的比较:一项队列研究。
Medicine (Baltimore). 2017 Jun;96(25):e7294. doi: 10.1097/MD.0000000000007294.
6
Comparison of visual outcomes after non-toric and toric implantable collamer lens V4c for myopia and astigmatism.非散光型和散光型可植入式 Collamer 透镜 V4c 治疗近视和散光的视觉效果比较。
Acta Ophthalmol. 2021 Aug;99(5):511-518. doi: 10.1111/aos.14652. Epub 2020 Oct 20.
7
One-year visual outcomes and optical quality of femtosecond laser small incision lenticule extraction and Visian Implantable Collamer Lens (ICL V4c) implantation for high myopia.飞秒激光小切口角膜基质透镜取出术与 Visian 可植入式 Collamer 透镜(ICL V4c)植入术治疗高度近视的 1 年视觉效果和光学质量评估。
Acta Ophthalmol. 2020 Sep;98(6):e662-e667. doi: 10.1111/aos.14344. Epub 2020 Jan 30.
8
Safety and efficacy of toric implantable collamer lens V4c model - A retrospective South Indian study.Toric 可植入 Collamer 透镜 V4c 模型的安全性和有效性-一项回顾性的印度南部研究。
Indian J Ophthalmol. 2020 Dec;68(12):3006-3011. doi: 10.4103/ijo.IJO_1492_20.
9
Visual outcomes of Visian ICL implantation for high myopia in patients with shallow anterior chamber depth.前房深度浅的高度近视患者植入Visian ICL后的视觉效果。
BMC Ophthalmol. 2019 May 29;19(1):121. doi: 10.1186/s12886-019-1132-z.
10
Etiology and Management of Raised Intraocular Pressure following Posterior Chamber Phakic Intraocular Lens Implantation in Myopic Eyes.近视眼中后房型有晶状体眼人工晶状体植入术后眼压升高的病因及处理
PLoS One. 2016 Nov 17;11(11):e0165469. doi: 10.1371/journal.pone.0165469. eCollection 2016.

引用本文的文献

1
Long-Term Evaluation of Central and Peripheral Lens Densities Post Implantation of Implantable Collamer Lens V4c.可植入式胶原晶状体V4c植入术后中央和周边晶状体密度的长期评估
Clin Ophthalmol. 2025 Feb 27;19:733-745. doi: 10.2147/OPTH.S500512. eCollection 2025.
2
Vertical implantable collamer lens as a novel method to increase rotational stability.垂直型可折叠 Collamer 透镜作为一种增加旋转稳定性的新方法。
PLoS One. 2024 Aug 19;19(8):e0308830. doi: 10.1371/journal.pone.0308830. eCollection 2024.
3
Five-year follow-up of a posterior chamber phakic intraocular lens with a central hole for correction of myopia.
中央孔型后房型有晶状体眼人工晶状体矫正近视的 5 年随访。
Int Ophthalmol. 2023 Dec;43(12):4933-4943. doi: 10.1007/s10792-023-02896-8. Epub 2023 Nov 7.
4
Multicenter clinical outcomes of hole implantable collamer lens implantation in middle-aged patients.多孔型 Collamer 人工晶状体植入治疗中年患者的多中心临床疗效观察
Sci Rep. 2022 Mar 10;12(1):4236. doi: 10.1038/s41598-022-08298-7.
5
Visual Outcomes, Footplate Position and Vault Achieved with the Visian Implantable Collamer Lens for Myopic Astigmatism.使用Visian可植入式角膜接触镜治疗近视散光的视觉效果、镫骨位置及前房深度
Clin Ophthalmol. 2021 Nov 20;15:4485-4497. doi: 10.2147/OPTH.S330879. eCollection 2021.
6
Posterior-chamber phakic implantable collamer lenses with a central port: a review.后房有孔型亲水性丙烯酸酯人工晶状体:综述。
Acta Ophthalmol. 2021 May;99(3):e288-e301. doi: 10.1111/aos.14599. Epub 2020 Aug 25.
7
Posterior-Chamber Phakic Intraocular Lens Implantation in Patients over 40 Years of Age.40岁以上患者的后房型有晶状体眼人工晶状体植入术
J Ophthalmol. 2020 Jun 29;2020:7457902. doi: 10.1155/2020/7457902. eCollection 2020.
8
The Implantable Collamer Lens with a central port: review of the literature.带中央端口的可植入胶原晶状体:文献综述
Clin Ophthalmol. 2018 Nov 27;12:2427-2438. doi: 10.2147/OPTH.S188785. eCollection 2018.
9
Two-Year Outcomes of Visian Implantable Collamer Lens with a Central Hole for Correcting High Myopia.用于矫正高度近视的带中心孔的Visian可植入式角膜胶原晶状体的两年随访结果
J Ophthalmol. 2018 Jul 3;2018:8678352. doi: 10.1155/2018/8678352. eCollection 2018.
10
[Intraocular pressure after implantation of an ICL with aquaport : Development of intraocular pressure after implantation of an ICL (model V4c) with aquaport without iridotomy].带水通道的可植入式接触镜(ICL)植入术后的眼压:带水通道(无虹膜切开术)的可植入式接触镜(V4c型)植入术后眼压的变化
Ophthalmologe. 2018 Jan;115(1):29-33. doi: 10.1007/s00347-017-0556-1.